Abstract
Nanotechnologies have already attracted over $3bn of global government funding
as part of efforts to enhance a range of disciplines including
pharmaceuticals, drug delivery and healthcare monitoring. Advances in
nanomaterials, nanostructures and nanosystems are expected to drive the value
of the global nanotehnology market to over a trillion dollars by 2015, but
many companies are remaining cautious, preferring to monitor developments in
academia prior to making substantial investments. Despite such trepidation,
the pharma industry is beginning to adopt nanotools throughout the R&D process
to facilitate the high throughput screening of drug repositories, the
identification of new drug targets and biomarkers for preclinical and clinical
studies and the development of diagnostics and imaging agents.
' Nanotechnology' is a new report published by Business Insights that provides
a comprehensive review of nanotechnology and it' s role in the development of
next-generation nanomedicines. The nanotools and detection systems currently
driving nanotechnology are profiled and the applications of nanotechnologies
within the R&D process are assessed. This report measures the impact of
nanotechnologies currently being applied to target cancer, cardiovascular
disease and CNS disorders and also explores the implementation strategies of
leading pharmaceutical, healthcare and nanotechnology start-ups.
Use this new report to assess the future of nanotechnology within pharma
R&D, identify the innovations driving growth within the market and examine the
implementation strategies of leading companies.
| 
View Cart
